Invention Grant
- Patent Title: Bicyclic derivatives as CETP inhibitors
-
Application No.: US13473649Application Date: 2012-05-17
-
Publication No.: US08410275B2Publication Date: 2013-04-02
- Inventor: Masashi Kishida , Naoko Matsuura , Hidetomo Imase , Yuki Iwaki , Ichiro Umemura , Osamu Ohmori , Eiji Kawahara
- Applicant: Masashi Kishida , Naoko Matsuura , Hidetomo Imase , Yuki Iwaki , Ichiro Umemura , Osamu Ohmori , Eiji Kawahara
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Sophie Binet Cross
- Priority: GB0609268.8 20060510
- Main IPC: C07D215/38
- IPC: C07D215/38
Abstract:
The present invention relates to novel compounds of formula (I) or a pharmaceutical composition thereof, with all the variables being defined in the text. The present invention further relates to the use of the compounds herein for treatment of or delay progression to overt to diseases in which CETP is involved.
Public/Granted literature
- US20120225874A1 BICYCLIC DERIVATIVES AS CETP INHIBITORS Public/Granted day:2012-09-06
Information query
